| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Vivekanand S Kattimani | Q57054215 |
| Avani Ganta | Q88245060 | ||
| P2093 | author name string | Rahul V C Tiwari | |
| P Srinivas Chakravarthi | |||
| P2860 | cites work | Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis | Q28305321 |
| Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand | Q28477393 | ||
| Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial | Q28972526 | ||
| Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 | ||
| Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines | Q30429578 | ||
| Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection | Q33414150 | ||
| Hepatitis E: an overview and recent advances in vaccine research. | Q34334086 | ||
| Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q34640567 | ||
| Global control of hepatitis B virus infection. | Q34749752 | ||
| Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality | Q35154918 | ||
| Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study | Q35918842 | ||
| Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study | Q36158727 | ||
| Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses | Q36693991 | ||
| Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women | Q36796538 | ||
| Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization | Q38177632 | ||
| Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial | Q42983179 | ||
| A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees | Q42998134 | ||
| AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection | Q43135807 | ||
| Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis | Q43974663 | ||
| The first vaccine against cancer: the human papillomavirus vaccine | Q44043086 | ||
| Immunogenicity, reactogenicity, and safety of human papillomavirus 16/18 AS04-adjuvanted vaccine in Japanese women: interim analysis of a phase II, double-blind, randomized controlled trial at month 7. | Q44598295 | ||
| Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial | Q45189946 | ||
| Hepatitis C--global prevalence (update) | Q73379666 | ||
| Summary and recommendations of single theme conferences on hepatitis B and C: Indian Association for Study of the Liver (INASL) | Q78631100 | ||
| Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011 | Q83096756 | ||
| HPV vaccine is now routinely indicated for males | Q83181439 | ||
| Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine | Q83235565 | ||
| Recommended adult immunization schedule: United States, 2012 | Q83384041 | ||
| Recommended adult immunization schedule-United States, 2013 | Q86603331 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 272-277 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Journal of International Society of Preventive and Community Dentistry | Q26853941 |
| P1476 | title | Adult immunization-Need of the hour | |
| P478 | volume | 6 |
| Q60310690 | Adult immunization – Need of the hour | cites work | P2860 |
Search more.